Leadership
Executive Council
Melanie Conrad, PhD
President
Melanie Conrad is a reproductive immunologist working at Charité Medical University Berlin and Augsburg University Hospital in Germany. Her research has contributed significantly to the developmental origins of health and disease hypothesis, examining how environmental influences during the perinatal time period affect 1) Maternal physiology during pregnancy and lactation, 2) Pregnancy outcomes, 3) Fetal and neonatal immune system development and 4) Childhood health outcomes in early life. As lead investigator of the EPPOCH longitudinal pregnancy cohort (Effect of the Pandemic on Pregnancy Outcomes and Childhood Health), her team has contributed to our understanding of how maternal mental health adversity during pregnancy impacts the maternal and infant microbiome and subsequent childhood health outcomes. In addition to human cohorts, she also specializes in proof-of-concept mouse models that mechanistically examine how antibiotic use or exposure to non-pathogenic bacteria during pregnancy affect immune system development and subsequent allergic asthma susceptibility in the offspring. Using this innovative top-down research design, she seeks to delineate the causal mechanisms contributing to the Developmental Origins of Health and Disease.
Marlou de Kroon, MD, PhD
Vice-President
Marlou de Kroon is a professor in Youth Health Care at the Department of Primary Care and Public Health at KU Leuven, Belgium, who is also associated with the University Medical Center Groningen, in the Netherlands. She has a passion for preventive child & youth health care and DOHaD research, utilizing mainly human cohort data. Her research investigates early prevention, and aims to unravel the causal biological pathways involved in topics related to early life stress, nutrition and other relevant predictors of childhood growth and development, especially in vulnerable populations such as preterm born and segregated Roma children. In addition to her research and her membership in the European DOHaD Society Executive, she is additionally the program manager of the Flemish interuniversity post-master training for Youth Health Care Physicians. In her free time, she enjoys walking in nature, gardening, cooking and enjoying & performing music.
Julie Sigurdardottir, PhD
Treasurer
Julie Sigurdardottir holds a BA in Psychology from the University of Iceland and a MSc in Neuroscience from University College London. Additionally, has a postgraduate diploma in Development and Psychopathology and a certificate in Trauma Studies from the University of Reading. In 2017 she joined King’s College London where she did her PhD in the department of Perinatal Imaging and Health. At present, she is a Research Associate affiliated with the department of Forensic and Neurodevelopmental Sciences at the Institute of Psychiatry, Psychology and Neuroscience. Within the DOHaD framework, she studies the effect of maternal obesity in pregnancy on offspring brain development and other important associated factors such as maternal depression, diet, infection and placental function. She also investigated the relationship between risks of obesity and psychopathology in young children of obese women. Utilising neonatal brain MRI data collected through the developing Human Connectome Project, she developed tractography protocols for white-matter pathways which could help explore predispositions to risk of both increased adiposity and neurodevelopmental conditions such as ASD and ADHD. She focuses particularly on the reward and autonomic nervous systems and hypothalamic function.
Amanda Sferruzzi-Perri, PhD
Secretary
The main goal of Amanda Sferruzzi-Perri’s research is to understand the aetiology of pregnancy complications so that effective treatments can be devised to improve the cardio-metabolic health and wellbeing of women and their families. These complications include abnormal birth weight, gestational diabetes, and preeclampsia, which have a combined effect of 15% on pregnancies in developed countries. Her work explores metabolic and cardiovascular adaptations to pregnancy and the role of the placenta by employing mouse models of environmental exposures (undernutrition, diet-induced obesity and hypoxia) and genetics (constitutive, conditional and knock-down). The goals of her research are to: 1) determine how the environment of the mother affects the placental phenotype and thereby regulates fetal nutrition, growth, and offspring outcome, and 2) examine how the placenta influences maternal metabolism and cardiovascular function via its endocrine function. She collaborates extensively with others using different experimental animal models and use samples donated by women across the globe to understand how we may translate our findings to improve human, and more broadly, mammalian health. Taking an integrative approach, by applying methods at the whole body, organ, structural, molecular and cellular levels, she hopes to identify diagnostic indicators and therapies for pregnancy complications, and understand the mechanistic basis of a poor pregnancy environment and increased risk to the offspring and mother post-pregnancy of subsequently developing type-2 diabetes and cardiovascular disease.
Hani Harb, PhD
Councillor
With over 15 years of experience in immunology and infectious disease research, Hani Harb is an Assistant Professor (Junior) at Dresden University of Technology in Germany. He leads a junior research group investigating the link between the gut microbiota and food allergies, with the mission to advance the understanding and treatment of allergic diseases, as well as to foster scientific collaboration and communication across disciplines and borders. Through his publications, presentations and leadership roles, he demonstrates his passion for immunogenetics, immunodiagnostics and stereology.
Jorge Lopez-Tello, PhD
Communications and publicity
Jorge Lopez-Tello is a junior group leader at the Autonomous University of Madrid, where he investigates the complex metabolic processes involved in pregnancy and the impact of pediatric diseases on lifelong health, using various animal models. He is particularly focused on developing new therapies to address pregnancy complications, including placental insufficiency and fetal growth restriction. He holds a degree in Veterinary Sciences and completed his PhD in 2017. He conducted his postdoctoral training at the University of Cambridge with support from the Royal Society and the Wellcome Trust. Outside the lab, he’s most likely found scuba-diving.
Advisory Board
Prof. Christine Heim
Charité Medical University - Berlin, Germany
Prof. Ana Zenclussen
Helmholtz Center for Environmental Research - Leipzig, Germany
Prof. Vincent Jaddoe
Erasmus University Medical Center - Rotterdam, Netherlands
Prof. Keith Godfrey
University Hospital Southampton, United Kingdom
Prof. Sue Ozanne
University of Cambridge, United Kingdom
Prof. Louise Howard
Kings College London, United Kingdom
Prof. Martine Vrijheid
Barcelona Institute for Global Health, Spain
Prof. Petter Brodin
Karolinska Institute - Stockholm, Sweden
Prof. Marie-Aline Charles
INSERM - Paris, France